Purchase Order HHSD2002015M87760P
- Not listed
- This federal contract award to Pacific Biosciences of California, Inc. is for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms, associated reagents, and support services. The $84,000.00 purchase order was issued by the Centers for Disease Control and Prevention (CDC) and does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology. The company has...
- This contract award is to Pacific Biosciences of California, Inc., a for-profit manufacturer, for the delivery of their Sequel and Sequel II DNA/RNA sequencing platforms and associated consumables to the Centers for Disease Control and Prevention (CDC). The $250,000.00 firm-fixed price purchase order has a performance period ending on December 31, 2025. Pacific Biosciences has established itself as a key supplier of specialized sequencing solutions to various federal agencies, as evidenced by...
- This federal contract award, valued at $84,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for a service agreement related to their Pacific Biosciences RS DNA Sequencer. The contract is a firm fixed-price purchase order without a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support...
- This is a firm-fixed price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Pacific Biosciences of California, Inc. for $84,000.00. The contract is for a service plan and has no set-aside designation. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) DNA/RNA sequencing technology. This contract award is likely part of Pacific Biosciences' broader work providing specialized sequencing...
- This is a firm-fixed price contract award to Pacific Biosciences of California, Inc. by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services. The $105,940 contract is for the provision of PacBio reagents, which are used in Pacific Biosciences' proprietary Sequel and Sequel II DNA/RNA sequencing platforms. These specialized sequencing systems and associated consumables are utilized by various federal civilian and defense agencies to support genomic research...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Pacific Biosciences of California, Inc., a for-profit manufacturer of specialized scientific equipment, reagents, and services. The $357,500.00 contract is for the provision of Pacific Biosciences' Sequel system, which includes the Sequel DNA/RNA sequencing instrument and associated consumables. The contract has no set-aside designation and is to be performed in...
- This is a federal contract award to Pacific Biosciences of California, Inc., a for-profit biotechnology company that specializes in high-throughput DNA and RNA sequencing technologies. The contract, valued at $15,047.06, was awarded by the Plains Area division of the U.S. Department of Agriculture (USDA) Agricultural Research Service, a civilian agency. The contract is for the provision of PacBio's SMRT DNA sequencing platforms, reagents, consumables, and associated services to support genomic...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $193,000.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to upgrade their PacBio Sequel System. This contract does not have a set-aside designation. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services associated with their Sequel and Sequel II DNA/RNA sequencing systems. They have fulfilled over $10 million in federal...
- This federal contract award is to Pacific Biosciences of California, Inc., a small business manufacturer of high-throughput, long-read DNA sequencing systems and associated consumables. The $22,845.96 firm-fixed price purchase order was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health, for the delivery of their Sequel and Sequel II sequencing platforms and related products. Pacific Biosciences holds two significant Indefinite...
- The U.S. government awarded a purchase order valued at $8,650 to Pacific Biosciences of California, Inc. for a Sequel Sequencing Kit on February 16, 2017, with completion by February 17, 2017. The contract was awarded on a firm fixed price basis with no set-aside designation to a civilian federal agency identified as Plains Area. Performance was established at Pacific Biosciences' location in Menlo Park, California. This award represents a direct procurement of sequencing reagents and...
This federal contract award to Pacific Biosciences of California, Inc. is for the provision of supplies related to SMRT sequencing technology. The $142,982.42 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services and has a period of performance ending on March 31, 2016. Pacific Biosciences is the original equipment manufacturer for their proprietary Sequel and Sequel II DNA/RNA sequencing platforms, which are utilized by various federal agencies to support genomic research initiatives. The company has established itself as a key supplier of specialized sequencing solutions, holding Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicles with the U.S. Department of Agriculture (USDA) and the Food and Drug Administration (FDA) valued at $13.5 million and $1 million, respectively. These IDIQs have enabled the procurement of sequencing instruments, consumables, and associated services for the agencies' agricultural and biomedical research programs. The contract award did not have a set-aside designation, reflecting Pacific Biosciences' position as the sole provider of their unique long-read sequencing technology to the federal government.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
SMRT Sequencer Supplies | 2015-Q-64250 | Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh | Award Notice 1/1 | 8/20/15, 4:07 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| 2 | Other Administrative Action | $0 | 3/16/16 | |
| 3 | Other Administrative Action | $0 | 3/16/16 | |
| 1 | Other Administrative Action | $0 | 3/9/16 | |
| Not listed | Not listed | $143.0k | 8/27/15 |